Results 241 to 250 of about 8,503,937 (347)

Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia. [PDF]

J Clin Med
Palmiero P, Caretto P, Ciccone MM, Maiello M, On Behalf Of The I C I S C U Italian Chapter Of International Society Cardiovascular Ultrasound.   +4 more
europepmc   +1 more source

Political changes and trends in cardiovascular risk factors in the Czech Republic, 1985-92. [PDF]

, 1997
Martin Bobák, Z Škodová, Z Písa, R. Poledne, Michael Marmot   +4 more
openalex   +1 more source

Development and Validation of Machine Learning‐Based Marker for Early Detection and Prognosis Stratification of Nonalcoholic Fatty Liver Disease

Advanced Science, EarlyView.
This study constructs a stacked multimodal machine learning model for nonalcoholic fattly liver disease (NAFLD) by integrating genetic and clinical features, and synthesize an in‐silico quantitative marker (ISNLD) that enables personalized risk stratification for intrahepatic and extrahepatic outcomes of high‐risk individuals of NAFLD.
Lushan Xiao, Lin Zeng, Jiaren Wang, Chang Hong, Ziyong Zhang, Chengkai Wu, Hao Cui, Yan Li, Ruining Li, Shengxing Liang, Qijie Deng, Wenyuan Li, Xuejing Zou, Pengcheng Ma, Li Liu   +14 more
wiley   +1 more source

Can Cardiovascular Risk Factors Be Predicted? The Case of Weight-Adjusted Waist Index. [PDF]

J Clin Hypertens (Greenwich)
Borghi C, Fiorini G.
europepmc   +1 more source

Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension [PDF]

, 1998
W WHITE
openalex   +1 more source

Alnustone Ameliorates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β‐Oxidation via Targeting Calmodulin

Advanced Science, EarlyView.
This study identifies alnustone, a natural compound from Alpinia katsumadai, as a potent therapeutic agent for MASLD and MASH. Alnustone enhances mitochondrial fatty acid β‐oxidation by directly targeting calmodulin, improving liver steatosis, fibrosis, and insulin resistance in vivo.
Shourui Hu, Xiaofan Liang, Yiming Qin, Yuxuan Li, Yue Liu, Congcong Liu, Zongxuan Lin, Chunxuan Geng, Yanqi Xu, Daimin Wei, Yingying Qin, Han Zhao, Yuqing Zhang, Zi‐Jiang Chen   +13 more
wiley   +1 more source

Microplastics and Nanoplastics: The Next Frontier of Cardiovascular Risk? [PDF]

JACC Adv
O' Dowling R.
europepmc   +1 more source

Cardiovascular Risk Factors and Blood Pressure Control in Continuous Ambulatory Peritoneal Dialysis

, 1993
Norbert Lameire
openalex   +1 more source

DNA‐PKcs‐Driven YAP1 Phosphorylation and Nuclear Translocation: a Key Regulator of Ferroptosis in Hyperglycemia‐Induced Cardiac Dysfunction in Type 1 Diabetes

Advanced Science, EarlyView.
In the context of chronic hyperglycemia, a DDR is initiated, leading to the pathological activation of DNA‐PKcs in the diabetic heart. This activated DNA‐PKcs directly interacts with and phosphorylates YAP1 at Thr226, thereby increasing the nuclear expression of YAP1.
Junyan Wang, Xing Chang, Chun Li, Jing Gao, Zhijiang Guo, Haowen Zhuang, Lingjun Wang, Yusheng Huang, Wei Wang, Chao Li, Qingyong He   +10 more
wiley   +1 more source

Lipoprotein (a) – Current status in the UK

Atherosclerosis Plus, 2022
S. Ansari, D. Neely, J. Payne, J. Cegla
doaj